218 related articles for article (PubMed ID: 22099822)
21. [Changes in calcium metabolism after kidney transplantation].
Berczi C; Asztalos L; Kincses Z; Országh I; Löcsey L; Balogh A; Balázs G
Magy Seb; 2001 Apr; 54(2):95-100. PubMed ID: 11339099
[TBL] [Abstract][Full Text] [Related]
22. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
Hamano T; Oseto S; Fujii N; Ito T; Katayama M; Horio M; Imai E; Hori M
Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
[TBL] [Abstract][Full Text] [Related]
23. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study.
Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
Nephrol Dial Transplant; 2011 Aug; 26(8):2691-5. PubMed ID: 21303965
[TBL] [Abstract][Full Text] [Related]
24. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?
Lomonte C; Antonelli M; Vernaglione L; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Basile C
J Nephrol; 2005; 18(1):96-101. PubMed ID: 15772930
[TBL] [Abstract][Full Text] [Related]
25. Treatment of hyperparathyroidism with cinacalcet in kidney transplant recipients.
Borstnar S; Erzen B; Gmeiner Stopar T; Kocjan T; Arnol M; Kandus A; Kovac D
Transplant Proc; 2010 Dec; 42(10):4078-82. PubMed ID: 21168632
[TBL] [Abstract][Full Text] [Related]
26. Calcium and phosphorus metabolism in stable renal transplant recipients.
Khosroshahi HT; Shoja MM; Azar SA; Tubbs RS; Safa J; Etemadi J; Ardalan MR
Exp Clin Transplant; 2007 Dec; 5(2):670-2. PubMed ID: 18194119
[TBL] [Abstract][Full Text] [Related]
27. Sevelamer hydrochloride improves hyperphosphatemia in hemodialysis patients with low bone turnover rate and low intact parathyroid hormone levels.
Kokuho T; Toya Y; Kawaguchi Y; Tamura K; Iwatsubo K; Dobashi Y; Nakazawa A; Takeda H; Iwatsubo M; Hirawa N; Yasuda G; Ohnishi T; Umemura S
Ther Apher Dial; 2007 Dec; 11(6):442-8. PubMed ID: 18028171
[TBL] [Abstract][Full Text] [Related]
28. Low-dose alfacalcidol controls secondary hyperparathyroidism in predialysis chronic kidney disease.
Reichel H
Nephron Clin Pract; 2010; 114(4):c268-76. PubMed ID: 20090369
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of intravenous paricalcitol in calcitriol-resistant hemodialysis patients with secondary hyperparathyroidism: 12-month prospective study.
Tonbul HZ; Solak Y; Atalay H; Turkmen K; Altintepe L
Ren Fail; 2012; 34(3):297-303. PubMed ID: 22251408
[TBL] [Abstract][Full Text] [Related]
30. Association of Helicobacter pylori IgG antibody with various demographic and biochemical parameters in kidney transplant recipients.
Baradaran A; Nasri H
Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1115-20. PubMed ID: 22089767
[TBL] [Abstract][Full Text] [Related]
31. Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study.
Ureña P; Jacobson SH; Zitt E; Vervloet M; Malberti F; Ashman N; Leavey S; Rix M; Os I; Saha H; Ryba M; Bencova V; Baños A; Zani V; Fouque D
Nephrol Dial Transplant; 2009 Sep; 24(9):2852-9. PubMed ID: 19369690
[TBL] [Abstract][Full Text] [Related]
32. The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism.
Schwarz A; Merkel S; Leitolf H; Haller H
Transplantation; 2011 Mar; 91(5):560-5. PubMed ID: 21192318
[TBL] [Abstract][Full Text] [Related]
33. Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience.
Lucchi L; Carboni C; Stipo L; Malaguti V; Ferrari F; Graziani R; Arletti S; Graziosi C
Artif Organs; 2011 Dec; 35(12):1186-93. PubMed ID: 21848793
[TBL] [Abstract][Full Text] [Related]
34. Normalization of intraoperative parathyroid hormone does not predict normal postoperative parathyroid hormone levels.
Starr FL; DeCresce R; Prinz RA
Surgery; 2000 Dec; 128(6):930-5;discussion 935-6. PubMed ID: 11114626
[TBL] [Abstract][Full Text] [Related]
35. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
36. Disorders of calcium metabolism at various times after renal transplantation.
Babarykin D; Adamsone I; Amerika D; Folkmane I; Rozental R
Ann Transplant; 1999; 4(1):46-53. PubMed ID: 10850601
[TBL] [Abstract][Full Text] [Related]
37. Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial.
Tzanakis IP; Papadaki AN; Wei M; Kagia S; Spadidakis VV; Kallivretakis NE; Oreopoulos DG
Int Urol Nephrol; 2008; 40(1):193-201. PubMed ID: 18193489
[TBL] [Abstract][Full Text] [Related]
38. Phosphorus control in peritoneal dialysis patients.
Yavuz A; Ersoy FF; Passadakis PS; Tam P; Evaggelos DM; Katopodis KP; Ozener C; Akçiçek F; Camsari T; Ateş K; Ataman R; Vlachojannis GJ; Dombros NA; Utaş C; Akpolat T; Bozfakioğlu S; Wu G; Karayaylali I; Arinsoy T; Stathakis CP; Yavuz M; Tsakiris DJ; Dimitriades AC; Yilmaz ME; Gültekin M; Süleymanlar G; Oreopoulos DG
Kidney Int Suppl; 2008 Apr; (108):S152-8. PubMed ID: 18379539
[TBL] [Abstract][Full Text] [Related]
39. Frequent recurrence of secondary hyperparathyroidism after pulse oral calcitriol withdrawal in PD patients.
Bajo MA; Selgas R; Possante C; Aguilera A; Sánchez C; Diaz C; de Alvaro F; Martinez ME
Adv Perit Dial; 1997; 13():239-43. PubMed ID: 9360690
[TBL] [Abstract][Full Text] [Related]
40. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
